Skip to main content
SpringerLink
Log in

Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis

  • Nephrology/Urology
  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In children treated by continuous ambulatory peritoneal dialysis (CAPD) renal anaemia is preferably treated by intraperitoneal administration of erythropoietin, since subcutaneous administration is painful and frightening for the child. Pharmacokinetics of erythropoietin were studied in three groups of children treated by CAPD. In group subcutaneous (SC) (n=5) erythropoietin was administered subcutaneously, whereas in group intraperitoneal 1 (IP1) (n=8) and intraperitoneal 2 (IP2) (n=8) erythropoietin was given intraperitoneally during a 12-h dwell. Group IP1 received erythropoietin in 20 ml/kg of dialysis fluid, while in group IP2 the hormone was added to only 50 ml of dialysate, irrespective of body weight. The median area under the curve (AUC) was 4064 mU·h/ml (range 2647–24357) in group SC, 1698 (570–5514) in group IP1 and 3577 (1225–6555) in group IP2. In comparison to group SC the AUC was significantly lower in group IP1 (Wilcoxon;P=0.02). The difference between group SC and group IP2 was not statistically significant.

In children on CAPD the resorption of erythropoietin after intraperitoneal administration, measured as AUC, is similar to subcutaneous administration, when erythropoietin is administered in 50 ml of dialysate. The dose needed to treat renal anaemia with erythropoietin administered intraperitoneally this way will have to be established in a therapeutic study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AUC :

area under the curve

CAPD :

continous ambulatory peritoneal dialysis

IP :

intraperitoneal

SC :

subcutaneous

References

  1. Alexander SR (1991) Pediatric uses of recombinant human erythropoietin: the outlook in 1991. Am J Kidney Dis 18: 42–53

    PubMed  Google Scholar 

  2. Ashai NI, Paganini EP, Wilson JM (1993) Intravenous versus subcutaneous dosing of epoetin: a review of the literature. Am J Kidney Dis 22 [Suppl 1]: 23–31

    PubMed  Google Scholar 

  3. Ateshkadi A, Johnson CA, Oxton LL, Hammond TG, Bohenek WS, Zimmerman SW (1993) Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continous ambulatory peritoneal dialysis. Am J Kidney Dis 21: 635–642

    PubMed  Google Scholar 

  4. Bargman JM, Breborowicz A, Rodela H, Sombolos K, Oreopoulos DG (1988) Intraperitoneal administration of recombinant human erythropoietin in uremic animals. Perit Dial Int 8: 249–252

    Google Scholar 

  5. Bargman JM, Jones JE, Petro JM (1992) The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate. Perit Dial Int 12: 369–372

    PubMed  Google Scholar 

  6. Benet JL, Galeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071–1074

    PubMed  Google Scholar 

  7. Bianchetti MG, Hämmerli I, Roduit C, Neuhaus TJ, Leumann EP, Oetliker OH (1991) Epoetin alfa in anaemic children or adolescents on regular dialysis. Eur J Pediatr 150: 509–512

    Article  PubMed  Google Scholar 

  8. Boelaert JR, Schurgers ML, Mattys EG, et al (1989) Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 9: 95–98

    PubMed  Google Scholar 

  9. Campos A, Garin EH (1992) Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Clin Pediatr 31: 94–99

    Google Scholar 

  10. Cheng IKP, Chan CCMK, Yu L, Fang GX, Wei D (1990) Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study. Clin Nephrol 35: 207–212

    Google Scholar 

  11. Eckardt KU, Kurtz A, Hirth P, Scigalla P, Wieczorek L, Bauer C(1988) Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klin Wochenschr 66: 241–245

    Article  PubMed  Google Scholar 

  12. Eidemak I, Friedberg MO, Ladefoged SD, Løkkegaard H, Pedersen E, Skielboe M (1992) Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD. Nephrol Dial Transplant 7: 526–529

    PubMed  Google Scholar 

  13. Eisele G, Bailie GR, Clement C, Wong E (1992) Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration. Perit Dial Int 12: 34–36

    PubMed  Google Scholar 

  14. Evans JHC, Brocklebank JT, Bowmer CJ, Ng PC (1991) Pharmacokinetics of recombinant human erythropoietin in children with renal failure. Nephrol Dial Transplant 6: 709–714

    PubMed  Google Scholar 

  15. Frenken LAM, Lier HJJ van, Gerlag PGG, Hartog M den, Koene RAP (1991) Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis. BMJ 303: 288

    PubMed  Google Scholar 

  16. Frenken LAM, Struijk DG, Coppens PJW, Tiggeler RGWL, Krediet RT, Koene RAP (1992) Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int 12: 378–383

    PubMed  Google Scholar 

  17. Grannolleras C, Leskopf W, Shaldon S, Fourcade J (1991) Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study. Clin Nephrol 36: 294–298

    PubMed  Google Scholar 

  18. Gurney CW, Wackman N, Filmanowitz E (1961) Studies on erythropoiesis, XVII. Some quantitative aspects of the erythropoietic response to erythropoietin. Blood 17: 531–546

    PubMed  Google Scholar 

  19. Hughes RT, Cotes PM, Oliver DO, et al (1989) Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD. Contrib Nephrol 76: 122–130

    PubMed  Google Scholar 

  20. Icardi A, Paoletti E, Molinelli G (1990) Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD. Adv Perit Dial 6: 292–295

    PubMed  Google Scholar 

  21. Korbet SM (1993) Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Kidney Int 43 [Suppl 40]: 111–119

    Google Scholar 

  22. Lane W, Robson M, Leung AKC, Zaretski JE (1993) The cost associated with intraperitoneal versus subcutaneous administration of erythropoietin. Eur J Pediatr 152: 377

    Google Scholar 

  23. Lui SF, Chung WWM, Leung CB, Chan K, Lai KN (1990) Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 33: 47–51

    PubMed  Google Scholar 

  24. Lui SF, Law CB, Ting SM, Li P, Lai KN (1990) Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 36: 246–251

    Google Scholar 

  25. MacDougall IC, Roberts DE, Neubert P, Dharmasena AD, Coles GA, Williams JD (1989) Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet I: 425–427

    Article  Google Scholar 

  26. MacDougall IC, Davies ME, Hutton RD, et al (1990) The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin. Nephrol Dial Transplant 5: 950–955

    PubMed  Google Scholar 

  27. Montini G, Zaccello G, Perfumo F, et al (1993) Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study. J Pediatr 122: 297–302

    PubMed  Google Scholar 

  28. Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H (1992) Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration. Perit Dial Int 12: 373–377

    PubMed  Google Scholar 

  29. Navarro M, Alonso A, Avilla JM, Espinosa L (1991) Anemia of chronic renal failure: treatment with erythropoietin. Child Nephrol Urol 11: 146–151

    PubMed  Google Scholar 

  30. Ongkinco JRC, Ruley EJ, Turner ME (1991) Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis. Am J Kidney Dis 18: 446–450

    PubMed  Google Scholar 

  31. Reddingius RE, Schröder CH, Monnens LAH (1992) Intraperitoneal administration of recombinant human erythropoietin in children on capd. Eur J Pediatr 151: 540–542

    Article  PubMed  Google Scholar 

  32. Reddingius RE, Schröder CH, Willems HL, et al (1994) Measurement of peritoneal fluid handling in children on CAPD using autologous haemoglobin. Perit Dial Int 14: 42–47

    PubMed  Google Scholar 

  33. Scigalla P (1992) Effect of different routes of recombinant human erythropoietin (rhEPO) in children with end stage renal failure (ESRD). Proceedings of the ninth congress of the International Pediatric Nephrology Association: 141A

  34. Sinai-Trieman L, Salusky IB, Fine RN (1989) Use of subcutaneous recombinant human erythropoietin in children undergoing continous cycling peritoneal dialysis. J Pediatr 114: 550–554

    PubMed  Google Scholar 

  35. Struijk DG, Koomen GCM, Krediet RT, Arisz L (1990) Accuracy of erythropoietin determination in the dialysate of CAPD patients. Adv Perit Dial 6: 289–291

    PubMed  Google Scholar 

  36. Veys N, Vanholder R, Lameire N (1992) Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin. Am J Nephrol 12: 68–72

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Sint Radboud University Hospital, P.O.B. 9101, NL-6500 HB, Nijmegen, The Netherlands

    R. E. Reddingius, C. H. Schröder & L. A. H. Monnens

  2. Department of Statistical Consultancy, Sint Radboud University Hospital, Nijmegen, The Netherlands

    A. M. Koster

Authors
  1. R. E. Reddingius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. H. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. A. H. Monnens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddingius, R.E., Schröder, C.H., Koster, A.M. et al. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis. Eur J Pediatr 153, 850–854 (1994). https://doi.org/10.1007/BF01972896

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972896

Key words

Search

Navigation